Navigation Links
Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
Date:7/23/2008

bability of success, the interim analysis provides us with the potential to accelerate our BLA amendment for PROVENGE," said Mitchell H. Gold, president and chief executive officer of Dendreon.

If the IDMC reports in October that the pre-specified criterion for statistical significance is not met, then the company anticipates continuing the trial with the expectation of reporting final results in the second half of 2009.

About IMPACT Study Design

The IMPACT trial is a multicenter, randomized, double-blind, placebo- controlled Phase 3 study, which enrolled just over 500 men with metastatic, androgen independent prostate cancer with a primary endpoint of overall survival. Dendreon is conducting the IMPACT trial under a Special Protocol Assessment (SPA) agreed upon with the FDA.

About Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than one million men in the United States have prostate cancer, with an estimated 186,320 new cases expected to be diagnosed in 2008, and approximately 28,660 men expected to die this year from the disease. Currently there are limited treatment options for men with advanced, metastatic prostate cancer.

About Active Cellular Immunotherapy with PROVENGE

PROVENGE may represent the first product in a new class of active cellular immunotherapies (ACIs) that are uniquely designed to use live human cells to engage the patient's own immune system with the goal of eliciting a specific long-lasting response against cancer. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its experti
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
4. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
5. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
8. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
9. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
10. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
11. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Calif. , May 24, 2013 Solta Medical, ... the medical aesthetics market, today reported Dr. Edward ... the Company,s Board of Directors effective immediately.  Dr. Knowlton is ... and had served as a director since 1996. ... as our management team, I would like to thank Ed ...
(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... in China , today announced that ... issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai ... that on May 21, 2013, Ms. Siu ... shareholders of the Company, and her spouse, Mr. Tung ...
(Date:5/24/2013)... , May 24, 2013  Sinovac Biotech ... provider of biopharmaceutical products in China ... operating subsidiary company of Sinovac, obtained the Certificate ... Certificate) from the China State and Food Administration ... bulk production plants, and its Changping filing and ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3
... ALTO, Calif., Oct. 12 Varian, Inc. (Nasdaq: ... for its 710-ES Series of ICP-OES (Inductively Coupled Plasma ... hardware, software and accessory options available both on new ... They enable users to reduce sample analysis times by ...
... Ill., Oct. 12 Hospira, Inc. (NYSE: HSP ), ... announced that the company will present at the Credit Suisse ... Phoenix, Ariz. , The presentation is scheduled to begin at ... It will be available to all interested parties through ...
Cached Medicine Technology:Varian, Inc. Delivers a Productivity Increase of Up to 100% With Its 710-ES Series ICP-OES 2Varian, Inc. Delivers a Productivity Increase of Up to 100% With Its 710-ES Series ICP-OES 3
(Date:5/25/2013)... 2013 Pradaxa lawsuits filed ... of internal bleeding while using the blood thinner continue to ... Southern District of Illinois, Bernstein Liebhard LLP reports. According ... effect claims had been filed in the litigation ... claims reported by the Court on May 15th. ( In ...
(Date:5/25/2013)... According to a new market report,"Global Homeland Security ... is expected to reach $544.02 Billion by 2018 ... studies the major market drivers, restraints, and opportunities ... the World. , Browse:, , ... Figures , 175 Pages and in-depth ...
(Date:5/25/2013)... Acuity Games ’ innovative brain games ... Word Hunt is available today, expanding it beyond ... Flash 2, Sudoku and Matchematics will roll out over the ... revolutionary lifetime brain fitness measurement have been re-optimized for the ... of brain fitness measurement in your pocket. What could ...
(Date:5/25/2013)... May 25, 2013 For college ... finals week. Increasingly, they are turning to prescription ... and study. For more on this, go to ... treatment facility, warns that students who pick up ... at risk for developing a physical and psychological ...
(Date:5/25/2013)... Flagstaff, Arizona (PRWEB) May 25, 2013 The ... Rehabilitation Center, their parents, and the B2B staff all came ... While everyone enjoyed an array of Indian Cuisine, the residents ... the company, for helping them on their road to recovery, ... started the Drug and Alcohol center in 2010 after realizing ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4Health News:Acuity Games Apps Come to the iPhone 2Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2
... Poor communication of the outcomes of medical tests whose ... hospital discharge is common and can lead to serious ... new study by researchers from the Regenstrief Institute and ... hospital discharge summaries are grossly inadequate at documenting both ...
... - Hard to Treat Diseases, Inc. (HTDS:PK), ( http://www.htdsmedical.com ... (Mellow Hope) announced today that the general manager of ... to a significant new business development opportunity related to ... to participate in a formal tender process to supply ...
... , , JEDDAH, Saudi ... feel beautiful and good about themselves, and Saudi women are ... which is such a strong guiding force in the kingdom? ... strict Muslim country. , http://susiesbigadventure.blogspot.com/2009/08/plastic-surgery-in-saudi-arabia.html ...
... that could change if fall outbreak proves more severe, ... The school closures that swept across the United States ... flu needn,t be repeated this fall, according to new ... the same guidelines noted that everything could change if ...
... Pharmaceutical Institute, a leading provider of specialized training solutions ... O,Grady has been appointed Senior Vice President and General Manager ... will manage the day-to-day operations of the business, as well ... teams. , , Mr. O,Grady has over ...
... , NEW YORK, Aug. 7 A ... vaccines beyond those received when they were infants or small children. ... most pre-teens and teens do not have all the vaccinations that ... certain diseases and protection from some childhood vaccines can wear off ...
Cached Medicine News:Health News:Fumbled handoffs can lead to medical errors 2Health News:Hard To Treat Diseases (HTDS) Chile Flu Vaccine Tender 2Health News:Hard To Treat Diseases (HTDS) Chile Flu Vaccine Tender 3Health News:Hard To Treat Diseases (HTDS) Chile Flu Vaccine Tender 4Health News:School Closures May Not Be Necessary When Swine Flu Strikes 2Health News:School Closures May Not Be Necessary When Swine Flu Strikes 3Health News:School Closures May Not Be Necessary When Swine Flu Strikes 4Health News:Garry O'Grady Appointed Senior Vice President and General Manager of Pharmaceutical Institute 2Health News:Photo: New Survey Results Show Most Moms Are Aware Their Pre-teens and Teens Need Vaccines 2Health News:Photo: New Survey Results Show Most Moms Are Aware Their Pre-teens and Teens Need Vaccines 3
Sub Pectoral Bra...
Bandeau Bra...
Post-Surgical compression garments...
... Cobalt Binding (ACB®) Test is a clinical ... (IMA®) by measuring the cobalt binding capacity ... First identified in the early 1990s, IMA ... contact with ischemic tissue in the heart. ...
Medicine Products: